Quick Answer
MADRIGAL PHARMACEUTICALS, INC. reported Stockholders Equity of $602.69 million for the year ending 2025.
- MADRIGAL PHARMACEUTICALS, INC. showed a decrease of -20.1% in Stockholders Equity from 2024 to 2025.
- This data is from MADRIGAL PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2014: $38.22 million | Q2 2014: $74.00 million | Q3 2014: $83.73 million | Q1 2015: $46.14 million | Q2 2015: $68.98 million | Q3 2015: $60.37 million | Q1 2016: $44.33 million | Q2 2016: $41.57 million | Q3 2016: $37.59 million | Q1 2017: $34.45 million | Q2 2017: $61.63 million | Q3 2017: $54.31 million | Q1 2018: $177.18 million | Q2 2018: $486.09 million | Q3 2018: $482.91 million | Q1 2019: $468.51 million | Q2 2019: $456.99 million | Q3 2019: $440.35 million | Q1 2020: $385.48 million | Q2 2020: $342.92 million | Q3 2020: $289.70 million | Q1 2021: $260.55 million | Q2 2021: $270.65 million | Q3 2021: $234.88 million | Q1 2022: $145.74 million | Q2 2022: $83.54 million | Q3 2022: $10.67 million | Q1 2023: $150.14 million | Q2 2023: $103.51 million | Q3 2023: $22.25 million | Q1 2024: $850.76 million | Q2 2024: $857.12 million | Q3 2024: $777.16 million | Q1 2025: $710.64 million | Q2 2025: $695.98 million | Q3 2025: $625.73 million.
- Over the full 15 years of available data (2011 to 2025), MADRIGAL PHARMACEUTICALS, INC.'s Stockholders Equity has grown by 3,979.4%.
- Historical annual values: Fiscal year 2025: $602.69 million | Fiscal year 2024: $754.38 million | Fiscal year 2023: $405.33 million | Fiscal year 2022: $197.39 million | Fiscal year 2021: $196.11 million | Fiscal year 2020: $239.97 million | Fiscal year 2019: $416.57 million | Fiscal year 2018: $476.98 million | Fiscal year 2017: $182.26 million | Fiscal year 2016: $36.41 million | Fiscal year 2015: -$48.91 million | Fiscal year 2014: -$42.07 million | Fiscal year 2013: $49.09 million | Fiscal year 2012: $75.07 million | Fiscal year 2011: $14.77 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: